Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
8
×
boston blog main
boston top stories
national top stories
san francisco top stories
new york blog main
new york top stories
biotech
cancer
national
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
loxo oncology
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
blueprint medicines
clinical trial
crispr
crispr therapeutics
dna sequencing
eli lilly
startups
study
2025
What
cancer
8
×
new
8
×
drug
genetic
medicine
medicines
therapeutics
bio
biotech
companies
crispr
cut
immunotherapy
ipo
medical
million
second
targets
time
aim
allogene
approved
athena
bets
black
boost
cas
cells
centers
ceo
change
chief
clinic
comes
community
countouriotis
date
deal
deeper
defect
Language
unset
Current search:
new
×
cancer
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?